Clinical practice guides

Clinical Cardiology

Volumn 32, Issue 4, 2009, Pages 174-175

  Conti, By C Richard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL; TELMISARTAN;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; COUGHING; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; EDITORIAL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FUNCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; PROGNOSIS; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZIMIDAZOLES; BENZOATES; DATA INTERPRETATION, STATISTICAL; HUMANS; MYOCARDIAL ISCHEMIA; RAMIPRIL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STATISTICS AS TOPIC;

EID: 64849084388     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20598     Document Type: Editorial

References (1)

1. The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358: 1547-1559.